IMPACT HIV Project
Investing for Impact against Tuberculosis (TB) and HIV is a one- year project funded by The Global Fund to fight AIDS, TB and Malaria (GFATM) in Nigeria. FHI 360, as the Principal Recipient (PR) has been assigned to work with pre-selected sub-recipients (SR) including CHEERS to provide HIV prevention, care, support and treatment services.
Nigeria has the second largest burden of both HIV and TB in Africa and is classified as a high TB, HIV, and MDR-TB burden country. According to the National AIDS and Reproductive Health Survey (NARHS) 2012, the current HIV prevalence in the general population is 3 - 4%, which indicates a downward trend from 4.196 in 2010. Prevalence differs per state and recent data show an increase in prevalence in some states. Six states (Kaduna, Akwa Ibom, Benue, Lagos, Oyo and Kano) were responsible for 41% of the HIV burden and 42% of new HIV infections annually. Twelve plus one (12+1) states were responsible for 65 - 9% of the new HIV infections and 63 - 4% of the HIV burden. Twenty-one states (20+1) contributed 81% of the national HIV burden. An estimated 3,459,363 million people were living with HIV in Nigeria in 2013. In 2011, an estimated 388,864 new infections occurred. In 2012 and 2013, 240,374 and 222,315 new infections, respectively, were estimated. In 2013, ART and PMTCI' coverage remain low at 33% and 21% respectively. Furthermore, HIV prevalence among key populations is significantly higher than the national average reported in 2012.
With a reported TB/HIV co-infection rate of 22% in 2013, the low coverage of both HIV and TB services presents a formidable challenge. In 2013, only 68% of PLHIV were screened for TB, 5% of eligible PLHIV received Isoniazid Preventive Therapy (IPT) and 67% of people co-infected with TB and HIV received ART. According to NARHS 2012, only 17% of Nigerians know their HIV status. Intensification of efforts to scale up prevention, detection and treatment of both diseases is therefore necessary.
This program will build on the results achieved to date through existing grants. Scale up efforts will be focused in five of the six TB/HIV high burden states for treatment (Kaduna, Anambra, Akwa Ibom, Rivers and Oyo) and 12+1 high burden states for PMTCI' (Kaduna, Anambra, Akwa Ibom, Rivers, Lagos, Oyo, Benue, Kano, Sokoto, Taraba, Nasarawa, Cross River and Federal Capital Territory). Lagos State Government is implementing a separate grant in the State of Lagos that covers scale-up in that state. The Program will contribute to the national goal to expand HIV/AIDS prevention, treatment, care and support in Nigeria to reduce HIV incidence and its associated morbidity and mortality.
In the period 2015-2017, this program will be implemented at federal level by four Principal Recipients, National Agency for the Control of AIDS (NACA), Association for Reproductive Health (ARFH), Society for Family Health (SFH) and, in 2017, Family Health International (FHI 360).
PROJECT GOALS AND OBJECTIVES
- To reduce new HIV infections, and improve the quality of life for the infected and affected;
- To provide Nigerians with universal access to high-quality, patient-centered prevention, diagnosis, and treatment services for TB, TB/HIV, and drug-resistant TB by 2020;
- To contribute to the restoration of public confidence in primary health care services in Nigeria, and thereby reverse declines in the utilization of primary health care facilities.